1. Home
  2. VCEL vs GAB Comparison

VCEL vs GAB Comparison

Compare VCEL & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$36.47

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Equity Trust Inc. (The)

GAB

Gabelli Equity Trust Inc. (The)

HOLD

Current Price

$6.01

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
GAB
Founded
1989
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
VCEL
GAB
Price
$36.47
$6.01
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$60.40
N/A
AVG Volume (30 Days)
592.9K
667.8K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
10.91%
EPS Growth
236.54
N/A
EPS
0.25
N/A
Revenue
$258,716,999.00
N/A
Revenue This Year
$17.86
N/A
Revenue Next Year
$18.55
N/A
P/E Ratio
$148.09
N/A
Revenue Growth
14.05
N/A
52 Week Low
$29.24
$4.56
52 Week High
$63.00
$5.88

Technical Indicators

Market Signals
Indicator
VCEL
GAB
Relative Strength Index (RSI) 44.40 42.90
Support Level $35.85 $6.15
Resistance Level $42.68 $6.29
Average True Range (ATR) 1.54 0.07
MACD -0.34 -0.01
Stochastic Oscillator 9.01 10.00

Price Performance

Historical Comparison
VCEL
GAB

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

Share on Social Networks: